BIVI - BioVie to Participate in the Truist Securities BioPharma Symposium | Benzinga
CARSON CITY, Nev., Nov. 02, 2023 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ:BIVI) ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced the participation of its management team in the Truist Securities BioPharma Symposium, to be held in New York, NY, November 8- 9, 2023.
Truist Securities BioPharma Symposium
Format: Panel presentation "Alzheimer's Disease: Exploring Late-Stage New Modalities in Alzheimer's Disease" and one-on-one investor meetings
Date: Wednesday, November 8, 2023
Time: 11:40 AM ET
Please contact your Truist Securities representative for additional information.
About BioVie
BioVie Inc. (NASDAQ:BIVI) is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease. In neurodegenerative ...